Health Care

NC Named Among Leaders In Biopharma Industry

By Christina Haley O'Neal, posted Aug 25, 2017
A new report highlights North Carolina as one of the top states in the nation for driving innovation and economic growth in the biopharmaceutical industry, amid an increasingly competitive global environment.

The report, recently released by national drug industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), points to attributes for the state: the N.C. Biotechnology Center (NCBiotech) and the state’s model for education and training to help close the skills gap.

Among the leading states, North Carolina was highlighted for its biopharmaceutical efforts along with Arizona, Texas, Massachusetts and Connecticut.

NCBiotech, a state chartered nonprofit, should serve as a model for other states in the nation in its ability to successfully attract and retain a wide range of biopharmaceutical companies, as well as its expansive network of higher education programs in biotech and biomanufacturing, university-driven labs and manufacturing facilities, contract services and workforce training, according to PhRMA.

NCBiotech has an office in Wilmington to cover the southeastern region of the state.

“North Carolina’s $86 billion life science economy is excelling at a time when the U.S. is looking to maintain its global leadership in biopharmaceutical research and development,” said Doug Edgeton, NCBiotech president and CEO. “These reports confirm that our regional assets uniquely support our statewide efforts to build, partner, invest and communicate. It has been, and will continue to be, transformative.”

Southeastern North Carolina has been a hub for significant contributions to the state’s advancement in the biotech and biopharmaceutical industries, said Randall Johnson, executive director of the NCBiotech’s Southeastern Office.

The biotech community in the region has a diverse range of industries. The Wilmington area is also tied to the state’s network of resources in the biopharmaceutical industry, with North Carolina being the No. 3 state in the nation based on the number of biotech companies, Johnson said.

“There are a number of things we have done, from investing in research, investing in programs and initiatives and educational opportunities that lead to support for the biopharmaceutical industry,” Johnson said. “We’ve also heavily supported the clinical research industry cluster here in the region that feeds directly into and is an important part of the biopharmaceutical industry in the state."
Ico insights


Burrus rob headshot 300x300

Business Leaders: Establish Partners And Mentors for Long-Term Success

Robert Burrus - Cameron School of Business - University of North Carolina Wilmington
20170717 101554 1 72117112436

Make A Wise Investment In Your Child’s Future

Steve Adams - School of Learning Arts

2017: Energy in the Spotlight

David McGowan, III - N.C. Petroleum Council; American Petroleum Institute-NC

Trending News

Pier 33 Apartments Developer Hoping For 2019 Finish

Cece Nunn - Sep 25, 2017

In The Current Issue

Looking At The Big Picture

Every business, large and small, wants a blueprint for long-term growth. Wilmington-based Tayloe/Gray, a firm providing branding, design, te...

2 Locals Picked For Creative Startups Contest Program

Two Wilmington firms are competing in Creative Startups in Winston-Salem, which kicks off this month and includes vying for $75,000 in angel...

Area Construction Costs On The Rise

As new homes and commercial spaces rise in the Wilmington area, so do construction costs....

Book On Business

The 2017 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!



Wilmington's Most Intriguing People of 2016
WilmingtonBiz Expo - Key Note Lunch with Keynote Lunch with Chip Mahan - 2016